Citations (80)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
Susann Kummer, Angelika Lander, Jonas Goretzko, Norman Kirchoff, Ursula Rescher & Sebastian Schloer. (2022) Pharmacologically induced endolysosomal cholesterol imbalance through clinically licensed drugs itraconazole and fluoxetine impairs Ebola virus infection in vitro. Emerging Microbes & Infections 11:1, pages 195-207.
Read now
Read now
Daniel Echeverria-Esnal, Clara Martín-Ontiyuelo, Maria Eugenia Navarrete-Rouco, Jaime Barcelo-Vidal, David Conde-Estévez, Nuria Carballo, Marta De-Antonio Cuscó, Olivia Ferrández, Juan Pablo Horcajada & Santiago Grau. (2022) Pharmacological management of antifungal agents in pulmonary aspergillosis: an updated review. Expert Review of Anti-infective Therapy 20:2, pages 179-197.
Read now
Read now
Sachin K. Jagdale & Rajesh B. Nawale. (2021) Experimental measurement – correlation of solubility and dissolution thermodynamics study of itraconazole in pure monosolvents at various temperatures. Drug Development and Industrial Pharmacy 47:7, pages 1038-1051.
Read now
Read now
Viktorija Dragojević-Simić, Aleksandra Kovačević, Vesna Jaćević, Nemanja Rančić, Snežana Djordjević, Vesna Kilibarda, Momir Mikov & Dubravko Bokonjić. (2018) Bioequivalence study of two formulations of itraconazole 100 mg capsules in healthy volunteers under fed conditions: a randomized, three-period, reference-replicated, crossover study. Expert Opinion on Drug Metabolism & Toxicology 14:9, pages 979-988.
Read now
Read now
Katharine E Stott & William Hope. (2018) Pharmacokinetics–pharmacodynamics of antifungal agents in the central nervous system. Expert Opinion on Drug Metabolism & Toxicology 14:8, pages 803-815.
Read now
Read now
Pierre-Régis Burgel, André Paugam, Dominique Hubert & Clémence Martin. (2016) Aspergillus fumigatus in the cystic fibrosis lung: pros and cons of azole therapy. Infection and Drug Resistance 9, pages 229-238.
Read now
Read now
Suganthini Krishnan Natesan & Pranatharthi H Chandrasekar. (2016) Isavuconazole for the treatment of invasive aspergillosis and mucormycosis: current evidence, safety, efficacy, and clinical recommendations. Infection and Drug Resistance 9, pages 291-300.
Read now
Read now
Xuezhi Yin, Linda Sharon Daintree, Sheng Ding, Daniel Mark Ledger, Bing Wang, Wenwen Zhao, Jianping Qi & Wei Wu. (2015) Itraconazole solid dispersion prepared by a supercritical fluid technique: preparation, in vitro characterization, and bioavailability in beagle dogs. Drug Design, Development and Therapy 9, pages 2801-2810.
Read now
Read now
Articles from other publishers (72)
Nayyer Islam, Naveed Ullah Khan, Anam Razzaq, Zaheer Ullah Khan, Farid Menaa, Mohammad Y. Alfaifi, Serag Eldin I. Elbehairi, Haroon Iqbal & Jiang Ni. (2023) Self-emulsifying micelles as a drug nanocarrier system for itraconazole oral bioavailability enhancement; in vitro and in vivo assessment. Saudi Pharmaceutical Journal 31:12, pages 101839.
Crossref
Crossref
Sai-li Xie, Xiayan Zhu, Nanyong Gao, Qianmeng Lin, Chaojie Chen, Yun-jun Yang, Jian-ping Cai, Guo-xin Hu & Ren-ai Xu. (2023) Genetic variations of CYP3A4 on the metabolism of itraconazole in vitro. Food and Chemical Toxicology 181, pages 114101.
Crossref
Crossref
Lokesh Bheemayya, Ravindra R. Kamble, Madivalagouda S. Sannaikar, Sanjeev R. Inamdar, Tukaram V. Metre, Barnabas Kodasi, Swati R. Hoolageri, Vishwa B. Nadoni, Shrinivas D. Joshi, Praveen Kumar S. K, Nagarjuna Prakash Dalbanjan, Mussuvir Pasha K M & Rangappa S. Keri. (2023)
Fe
3
O
4
Nanoparticles Catalyzed Tandem Synthesis of Fluorescent 3‐(4,5‐diaryl‐1
H
‐imidazol‐2‐yl) quinoline‐2‐amines: Solvatochromic, DFT and Biological Studies
. ChemistrySelect 8:40.
Crossref
Crossref
Richard E. Kast. (2023) The OSR9 Regimen: A New Augmentation Strategy for Osteosarcoma Treatment Using Nine Older Drugs from General Medicine to Inhibit Growth Drive. International Journal of Molecular Sciences 24:20, pages 15474.
Crossref
Crossref
Wenping Wang, Honami Kojima, Ming Gao, Xingbin Yin, Takahiro Uchida & Jian Ni. (2023) Optimization of O/W Emulsion Solvent Evaporation Method for Itraconazole Sustained Release Microspheres. Chemical and Pharmaceutical Bulletin 71:7, pages 520-527.
Crossref
Crossref
Lulu Pan, Xiaxia Fan, Ao Jia, Yafei Li, Yidan Zhao, Ying Liu, Aifeng Wang & Yongcheng Ma. (2023) High-throughput identification and determination of antifungal triazoles in human plasma using UPLC-QDa. Journal of Chromatography B 1226, pages 123774.
Crossref
Crossref
Eunsol Yang, Kyung‐Sang Yu & SeungHwan Lee. (2023)
Prediction of gastric
pH
‐mediated drug exposure using physiologically‐based pharmacokinetic modeling: A case study of itraconazole
. CPT: Pharmacometrics & Systems Pharmacology 12:6, pages 865-877.
Crossref
Crossref
Syed Mujtaba Hussain Naqvi, Monil Yogesh Neena Gala, Snehal Muchhala, Anand Arumugam, Dhananjay Panigrahi, Dipak Patil, Rahul Rathod & Amey Mane. (2023) Pharmacokinetics/Pharmacodynamics study of Fixtral SB as compared to supra bioavailable itraconazole and conventional itraconazole. World Journal of Pharmacology 12:1, pages 1-11.
Crossref
Crossref
Davide Pirolli, Benedetta Righino, Chiara Camponeschi, Francesco Ria, Gabriele Di Sante & Maria Cristina De Rosa. (2023) Virtual screening and molecular dynamics simulations provide insight into repurposing drugs against SARS-CoV-2 variants Spike protein/ACE2 interface. Scientific Reports 13:1.
Crossref
Crossref
Samar Sami Alkafaas, Abanoub Mosaad Abdallah, Soumya Ghosh, Samah A. Loutfy, Sara Samy Elkafas, Nasra F. Abdel Fattah & Mohamed Hessien. (2022) Insight into the role of clathrin‐mediated endocytosis inhibitors in SARS‐CoV‐2 infection. Reviews in Medical Virology 33:1.
Crossref
Crossref
Kanjana Mahanil, Pachara Sattayawat, Jeeraporn Pekkoh, Masafumi Kameya, Masaharu Ishii & Chayakorn Pumas. (2022) Simple transformation of the filamentous thermophilic cyanobacterium Leptolyngbya sp. KC45. Algal Research 66, pages 102758.
Crossref
Crossref
Milijana N. Miljković, Nemanja Rančić, Aleksandra Kovačević, Bojana Cikota-Aleksić, Ivan Skadrić, Vesna Jaćević, Momir Mikov & Viktorija Dragojević-Simić. (2022) Influence of Gender, Body Mass Index, and Age on the Pharmacokinetics of Itraconazole in Healthy Subjects: Non-Compartmental Versus Compartmental Analysis. Frontiers in Pharmacology 13.
Crossref
Crossref
Aadith Ashok, Rekha Pai Mangalore & C. Orla Morrissey. (2022) Azole Therapeutic Drug Monitoring and its Use in the Management of Invasive Fungal Disease. Current Fungal Infection Reports 16:2, pages 55-69.
Crossref
Crossref
Lu Chen, Lixian Li & Wanyi Chen. (2022) Use of Modeling and Simulation to Predict the Influence of Triazole Antifungal Agents on the Pharmacokinetics of Crizotinib. Clinical Pharmacology in Drug Development 11:6, pages 724-733.
Crossref
Crossref
Georgios Stroulios, Tyler Brown, Giulia Moreni, Douglas Kondro, Alessandro Dei, Allen Eaves, Sharon Louis, Juan Hou, Wing Chang, Dasja Pajkrt, Katja C. Wolthers, Adithya Sridhar & Salvatore Simmini. (2022) Apical-out airway organoids as a platform for studying viral infections and screening for antiviral drugs. Scientific Reports 12:1.
Crossref
Crossref
Sebastian Schloer, Jonas Goretzko & Ursula Rescher. (2022) Repurposing Antifungals for Host-Directed Antiviral Therapy?. Pharmaceuticals 15:2, pages 212.
Crossref
Crossref
Nimmy Raj, Murugesan Vanathi, Nishat Hussain Ahmed, Noopur Gupta, Neiwete Lomi & Radhika Tandon. (2021) Recent Perspectives in the Management of Fungal Keratitis. Journal of Fungi 7:11, pages 907.
Crossref
Crossref
Katharine E. Stott, Thuy Le, Thu Nguyen, Sarah Whalley, Jennifer Unsworth, Vo Trieu Ly, Ruwanthi Kolamunnage-Dona & William Hope. (2021) Population Pharmacokinetics and Pharmacodynamics of Itraconazole for Disseminated Infection Caused by Talaromyces marneffei. Antimicrobial Agents and Chemotherapy 65:11.
Crossref
Crossref
Saraswathi Nagaraj, Sivakami Manivannan & Shoba Narayan. (2021) Potent antifungal agents and use of nanocarriers to improve delivery to the infected site: A systematic review. Journal of Basic Microbiology 61:10, pages 849-873.
Crossref
Crossref
Adriana M. Rauseo, Patrick Mazi, Phoebe Lewis, Bruce Burnett, Stuart Mudge & Andrej Spec. (2021) Bioavailability of Single-Dose SUBA-Itraconazole Compared to Conventional Itraconazole under Fasted and Fed Conditions. Antimicrobial Agents and Chemotherapy 65:8.
Crossref
Crossref
Dhiraj Dhoot, Piyush Prabhat, Lalita Mayadeo & Harshal Mahajan. (2021) Comparison of various regimens of itraconazole in treatment of acute vulvovaginal candidiasis. Indian Journal of Obstetrics and Gynecology Research 8:2, pages 244-249.
Crossref
Crossref
Sebastian Schloer, Linda Brunotte, Angeles Mecate‐Zambrano, Shuyu Zheng, Jing Tang, Stephan Ludwig & Ursula Rescher. (2021) Drug synergy of combinatory treatment with remdesivir and the repurposed drugs fluoxetine and itraconazole effectively impairs SARS‐CoV‐2 infection in vitro. British Journal of Pharmacology 178:11, pages 2339-2350.
Crossref
Crossref
Andi Dian Permana, Rifka Nurul Utami, Patricia Layadi, Achmad Himawan, Nana Juniarti, Qonita Kurnia Anjani, Emilia Utomo, Sandra Aulia Mardikasari, Andi Arjuna & Ryan F. Donnelly. (2021) Thermosensitive and mucoadhesive in situ ocular gel for effective local delivery and antifungal activity of itraconazole nanocrystal in the treatment of fungal keratitis. International Journal of Pharmaceutics 602, pages 120623.
Crossref
Crossref
Melissa D. Johnson. (2021) Antifungals in Clinical Use and the Pipeline. Infectious Disease Clinics of North America 35:2, pages 341-371.
Crossref
Crossref
S. Kroon, R. J. Snijder, A. E. Hosman, V. M.M. Vorselaars, F. J.M Disch, M. C. Post & J. J. Mager. (2020) Oral itraconazole for epistaxis in hereditary hemorrhagic telangiectasia: a proof of concept study. Angiogenesis 24:2, pages 379-386.
Crossref
Crossref
Arghadip Samaddar & Anuradha Sharma. (2021) Emergomycosis, an Emerging Systemic Mycosis in Immunocompromised Patients: Current Trends and Future Prospects. Frontiers in Medicine 8.
Crossref
Crossref
Qiuying Liao & Jenny K.W. Lam. (2021) Inhaled Antifungal Agents for the Treatment and Prophylaxis of Pulmonary Mycoses. Current Pharmaceutical Design 27:12, pages 1453-1468.
Crossref
Crossref
Yue Li, Shuncong Wang, Xiao Jiang, Xiaoxiong Wang, Xiang Zhou, Liangrong Wan, Haitao Zhao, Zhaoli Zhou, LingJie Gao, Gang Huang, Yicheng Ni & Xiaoyan He. (2021) Preparation and validation of cyclodextrin-based excipients for radioiodinated hypericin applied in a targeted cancer radiotherapy. International Journal of Pharmaceutics 599, pages 120393.
Crossref
Crossref
Quanhathai Kaewpoowat, Romanee Chaiwarith, Saowaluck Yasri, Navaporn Worasilchai, Ariya Chindamporn, Thira Sirisanthana & Tim R Cressey. (2021) Drug–drug interaction between itraconazole capsule and efavirenz in adults with HIV for talaromycosis treatment. Journal of Antimicrobial Chemotherapy 76:4, pages 1041-1045.
Crossref
Crossref
Hansraj Choudhary, Shreya Singh, Rachna Singh, Ritesh Agarwal, Harsimran Kaur, Anup Ghosh, Arunaloke Chakrabarti & Shivaprakash M. Rudramurthy. (2021) Rapid and Simple Reversed-Phase High-Performance Liquid Chromatography (RP-HPLC) Method for Simultaneous Quantifications of Triazole Antifungals in Human Serum. Mycopathologia 186:1, pages 27-39.
Crossref
Crossref
Ryota Tanaka, Yosuke Suzuki, Hiroyuki Matsumoto, Mari Yamasue, Kenji Umeki, Kazuhiko Hashinaga, Ryosuke Tatsuta, Kazufumi Hiramatsu, Katsuhiko Kamei, Jun‐ichi Kadota & Hiroki Itoh. (2021) Significant elevation of free itraconazole concentration at onset of adverse effects: A case report. Clinical Case Reports 9:3, pages 1187-1192.
Crossref
Crossref
Zhongyi Ma, Xiaoyou Wang & Chong Li. (2020) Strategies of Drug Delivery for Deep Fungal Infection: A Review. Pharmaceutical Nanotechnology 8:5, pages 372-390.
Crossref
Crossref
A. Gómez-López. (2020) Antifungal therapeutic drug monitoring: focus on drugs without a clear recommendation. Clinical Microbiology and Infection 26:11, pages 1481-1487.
Crossref
Crossref
Mariana Nunes, Miguel Henriques Abreu, Carla Bartosch & Sara Ricardo. (2020) Recycling the Purpose of Old Drugs to Treat Ovarian Cancer. International Journal of Molecular Sciences 21:20, pages 7768.
Crossref
Crossref
Gari Kasparyan, Chetan Poojari, Tomasz Róg & Jochen S. Hub. (2020) Cooperative Effects of an Antifungal Moiety and DMSO on Pore Formation over Lipid Membranes Revealed by Free Energy Calculations. The Journal of Physical Chemistry B 124:40, pages 8811-8821.
Crossref
Crossref
George R. ThompsonIIIIII, Phoebe Lewis, Stuart Mudge, Thomas F. Patterson & Bruce P. Burnett. (2020) Open-Label Crossover Oral Bioequivalence Pharmacokinetics Comparison for a 3-Day Loading Dose Regimen and 15-Day Steady-State Administration of SUBA-Itraconazole and Conventional Itraconazole Capsules in Healthy Adults. Antimicrobial Agents and Chemotherapy 64:8.
Crossref
Crossref
Sebastian Schloer, Jonas Goretzko, Stephan Pleschka, Stephan Ludwig & Ursula Rescher. (2020) Combinatory Treatment with Oseltamivir and Itraconazole Targeting Both Virus and Host Factors in Influenza A Virus Infection. Viruses 12:7, pages 703.
Crossref
Crossref
Samihah Moazam, Christopher Philip Eades, Eavan Gabrielle Muldoon, Caroline B. Moore, Malcolm D. Richardson & Riina Rautemaa‐Richardson. (2020)
Positive
Aspergillus
PCR as a marker of azole resistance or sub‐therapeutic antifungal therapy in patients with chronic pulmonary aspergillosis
. Mycoses 63:4, pages 376-381.
Crossref
Crossref
Yassamin N. Albayaty, Nicky Thomas, Paulina D. Ramírez-García, Thomas P. Davis, John F. Quinn, Michael R. Whittaker & Clive A. Prestidge. (2020)
pH-Responsive copolymer micelles to enhance itraconazole efficacy against
Candida albicans
biofilms
. Journal of Materials Chemistry B 8:8, pages 1672-1681.
Crossref
Crossref
Jaana Rytkönen, Veli‐Pekka Ranta, Merja Kokki, Hannu Kokki, Heidi Hautajärvi, Valtteri Rinne & Aki T. Heikkinen. (2020) Physiologically based pharmacokinetic modelling of oxycodone drug–drug interactions. Biopharmaceutics & Drug Disposition 41:1-2, pages 72-88.
Crossref
Crossref
Amit V. Desai, David Han, Donna L. Kowalski, Christopher Lademacher, Helene Pearlman & Takao Yamazaki. (2019) No Dose Adjustment for Isavuconazole Based on Age or Sex. Antimicrobial Agents and Chemotherapy 63:6.
Crossref
Crossref
Jingxiang Zhang, Liping Li, Quanzhen Lv, Lan Yan, Yan Wang & Yuanying Jiang. (2019) The Fungal CYP51s: Their Functions, Structures, Related Drug Resistance, and Inhibitors. Frontiers in Microbiology 10.
Crossref
Crossref
Fan Jiang, Hong‐S. Xing, Wei‐Y. Chen, Jie Du, Yue‐l. Ruan, An‐Y. Lin & Chi‐Z. Zhou. (2018) Itraconazole inhibits proliferation of pancreatic cancer cells through activation of Bak‐1. Journal of Cellular Biochemistry 120:3, pages 4333-4341.
Crossref
Crossref
Inmaculada Galindo, Miguel Cuesta-Geijo, Ana del Puerto, Eva Soriano & Covadonga Alonso. (2019) Lipid Exchange Factors at Membrane Contact Sites in African Swine Fever Virus Infection. Viruses 11:3, pages 199.
Crossref
Crossref
Yusuke Kobayashi, Kouji Banno, Haruko Kunitomi, Eiichiro Tominaga & Daisuke Aoki. (2019) Current state and outlook for drug repositioning anticipated in the field of ovarian cancer. Journal of Gynecologic Oncology 30:1.
Crossref
Crossref
Ying Hua Leong, Alison Boast, Noel Cranswick, Nigel Curtis & Amanda Gwee. (2019) Itraconazole Dosing and Drug Monitoring at a Tertiary Children’s Hospital. Pediatric Infectious Disease Journal 38:1, pages 60-64.
Crossref
Crossref
Nikolaos Spernovasilis & Diamantis Kofteridis. (2018) Pre-Existing Liver Disease and Toxicity of Antifungals. Journal of Fungi 4:4, pages 133.
Crossref
Crossref
Alicia Gomez-Lopez, Laura Alcazar-Fuoli & Leticia Bernal-Martínez. (2018) Simultaneous quantification of systemic azoles and their major metabolites in human serum by HPLC/PDA: role of azole metabolic rate. Diagnostic Microbiology and Infectious Disease 92:1, pages 78-83.
Crossref
Crossref
Lisa Bauer, Salvatore Ferla, Sarah A. Head, Shridhar Bhat, Kalyan K. Pasunooti, Wei Q. Shi, Lucian Albulescu, Jun O. Liu, Andrea Brancale, Frank J.M. van Kuppeveld & Jeroen R.P.M. Strating. (2018) Structure-activity relationship study of itraconazole, a broad-range inhibitor of picornavirus replication that targets oxysterol-binding protein (OSBP). Antiviral Research 156, pages 55-63.
Crossref
Crossref
Ahmad Y. Abuhelwa, Stuart Mudge, Richard N. Upton & David J. R. Foster. (2017) Population in vitro–in vivo pharmacokinetic model of first-pass metabolism: itraconazole and hydroxy-itraconazole. Journal of Pharmacokinetics and Pharmacodynamics 45:2, pages 181-197.
Crossref
Crossref
Kenneth Crombie, Zandile Spengane, Michael Locketz, Sipho Dlamini, Rannakoe Lehloenya, Sean Wasserman, Tsidiso G. Maphanga, Nelesh P. Govender, Chris Kenyon & Ilan S. Schwartz. (2018) Paradoxical worsening of Emergomyces africanus infection in an HIV-infected male on itraconazole and antiretroviral therapy. PLOS Neglected Tropical Diseases 12:3, pages e0006173.
Crossref
Crossref
Douglas A. Hamilton, Cynthia C. ErnstWilliam G. Kramer, Donna MaddenEric LangEdward LiaoPeter G. Lacouture, Atulkumar Ramaiya & Daniel B. Carr. (2018) Pharmacokinetics of Diclofenac and Hydroxypropyl-β-Cyclodextrin (HPβCD) Following Administration of Injectable HPβCD-Diclofenac in Subjects With Mild to Moderate Renal Insufficiency or Mild Hepatic Impairment. Clinical Pharmacology in Drug Development 7:2, pages 110-122.
Crossref
Crossref
Ilan S Schwartz & Sean Wasserman. (2017) Itraconazole and antiretroviral therapy: strategies for empirical dosing. The Lancet Infectious Diseases 17:11, pages 1122-1123.
Crossref
Crossref
Jae-Sug Lee, Hwa-Jung Choi, Jae-Hyoung Song, Hyun-Jeong Ko, Kyungah Yoon & Jeong-Min Seong. (2017)
Antiviral Activity of Itraconazole against Echovirus 30 Infection
In Vitro
. Osong Public Health and Research Perspectives 8:5, pages 318-324.
Crossref
Crossref
Richard E. Kast, Nicolas Skuli, Georg Karpel-Massler, Guido Frosina, Timothy Ryken & Marc-Eric Halatsch. (2017) Blocking epithelial-to-mesenchymal transition in glioblastoma with a sextet of repurposed drugs: the EIS regimen. Oncotarget 8:37, pages 60727-60749.
Crossref
Crossref
A.E. Hasbach, D.K. Langlois, E.J. RosserJrJr & M.G. Papich. (2017) Pharmacokinetics and Relative Bioavailability of Orally Administered Innovator‐Formulated Itraconazole Capsules and Solution in Healthy Dogs. Journal of Veterinary Internal Medicine 31:4, pages 1163-1169.
Crossref
Crossref
Martina Stepankova, Barbora Pastorkova, Petr Bachleda & Zdenek Dvorak. (2017) Itraconazole cis -diastereoisomers activate aryl hydrocarbon receptor AhR and pregnane X receptor PXR and induce CYP1A1 in human cell lines and human hepatocytes. Toxicology 383, pages 40-49.
Crossref
Crossref
Katharine E. Stott & William W. Hope. (2017) Therapeutic drug monitoring for invasive mould infections and disease: pharmacokinetic and pharmacodynamic considerations. Journal of Antimicrobial Chemotherapy 72:suppl_1, pages i12-i18.
Crossref
Crossref
William Hope, George L. Drusano & John H. Rex. (2016) Pharmacodynamics for antifungal drug development: an approach for acceleration, risk minimization and demonstration of causality. Journal of Antimicrobial Chemotherapy 71:11, pages 3008-3019.
Crossref
Crossref
K. J. G. Brouwers, R. Vis & R. A. Tupker. (2015) Itraconazole as a continuous treatment for atopic dermatitis? A case report. Journal of the European Academy of Dermatology and Venereology 30:5, pages 873-874.
Crossref
Crossref
Chaoping Liang, Qi Shan, Jialian Zhong, Wei Li, Xiufeng Zhang, Jing Wang, Changfu Cao & Zhenling Zeng. (2015) Pharmacokinetics and bioavailability of itraconazole oral solution in cats. Journal of Feline Medicine and Surgery 18:4, pages 310-314.
Crossref
Crossref
Nicolette R. Holt & Karin A. Thursky. 2016. Drug Dosing in Obesity. Drug Dosing in Obesity
77
96
.
David J. Greenblatt & Jerold S. Harmatz. (2015) Ritonavir is the best alternative to ketoconazole as an index inhibitor of cytochrome P450-3A in drug-drug interaction studies. British Journal of Clinical Pharmacology 80:3, pages 342-350.
Crossref
Crossref
Aditya K. GuptaMaryse Paquet. (2015) Management of Onychomycosis in Canada in 2014. Journal of Cutaneous Medicine and Surgery 19:3, pages 260-273.
Crossref
Crossref
Jeroen R.P.M. Strating, Lonneke van der Linden, Lucian Albulescu, Joëlle Bigay, Minetaro Arita, Leen Delang, Pieter Leyssen, Hilde M. van der Schaar, Kjerstin H.W. Lanke, Hendrik Jan Thibaut, Rachel Ulferts, Guillaume Drin, Nina Schlinck, Richard W. Wubbolts, Navdar Sever, Sarah A. Head, Jun O. Liu, Philip A. Beachy, Maria A. De Matteis, Matthew D. Shair, Vesa M. Olkkonen, Johan Neyts & Frank J.M. van Kuppeveld. (2015) Itraconazole Inhibits Enterovirus Replication by Targeting the Oxysterol-Binding Protein. Cell Reports 10:4, pages 600-615.
Crossref
Crossref
Barbara Grzegorczyk & Yoshihiko Murata. (2014) Peripheral eosinophilia and eosinophilic colitis during long‐term azole therapy for pulmonary aspergillosis. JMM Case Reports 1:4.
Crossref
Crossref
Michael J. Dolton & Andrew J. McLachlan. (2014) Optimizing azole antifungal therapy in the prophylaxis and treatment of fungal infections. Current Opinion in Infectious Diseases 27:6, pages 493-500.
Crossref
Crossref
H. Karl Greenblatt & David J. Greenblatt. (2014) Liver injury associated with ketoconazole: Review of the published evidence. The Journal of Clinical Pharmacology 54:12, pages 1321-1329.
Crossref
Crossref
Richard E. Kast, Georg Karpel-Massler & Marc-Eric Halatsch. (2014) CUSP9* treatment protocol for recurrent glioblastoma: aprepitant, artesunate, auranofin, captopril, celecoxib, disulfiram, itraconazole, ritonavir, sertraline augmenting continuous low dose temozolomide. Oncotarget 5:18, pages 8052-8082.
Crossref
Crossref
H. R. Ashbee, R. A. Barnes, E. M. Johnson, M. D. Richardson, R. Gorton & W. W. Hope. (2013) Therapeutic drug monitoring (TDM) of antifungal agents: guidelines from the British Society for Medical Mycology. Journal of Antimicrobial Chemotherapy 69:5, pages 1162-1176.
Crossref
Crossref
H.R. Ashbee & M.H. Gilleece. 2014. Handbook of Pharmacogenomics and Stratified Medicine. Handbook of Pharmacogenomics and Stratified Medicine
879
900
.
Maiken C. Arendrup, Manuel Cuenca-Estrella, Cornelia Lass-Flörl & William W. Hope. (2013) Breakpoints for antifungal agents: An update from EUCAST focussing on echinocandins against Candida spp. and triazoles against Aspergillus spp.. Drug Resistance Updates 16:6, pages 81-95.
Crossref
Crossref